Expert Guidelines for the Management of Alport Syndrome and Thin Basement Membrane NephropathyJudy Savige, Frances Flinter, Martin C. Gregory et al.|Journal of the American Society of Nephrology|2013Cited by 385
A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport’s syndromeOliver Groß, Markus Feldkoetter, Baerbel Lange‐Sperandio et al.|Kidney International|2020Cited by 151
Temporal Bone Histopathology in Alport SyndromeSaumil N. Merchant, Joseph B. Nadol, Barbara J. Burgess et al.|The Laryngoscope|2004Cited by 72